Literature DB >> 11435613

Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.

N Akutsu1, R Lin, Y Bastien, A Bestawros, D J Enepekides, M J Black, J H White.   

Abstract

Analogs of 1alpha,25-dihydroxyvitamin D(3) (1alpha, 25(OH)2D3) inhibit growth in vitro and in vivo of cells derived from a variety of tumors. Here, we examined the effects of 1alpha,25(OH)2D3 and its analog EB1089 on proliferation and target gene regulation of human head and neck squamous cell carcinoma (SCC) lines SCC4, SCC9, SCC15, and SCC25. A range of sensitivities to 1alpha,25(OH)2D3 and EB1089 was observed, from complete G0/G1 arrest of SCC25 cells to only 50% inhibition of SCC9 cell growth. All lines expressed similar levels of vitamin D3 receptor (VDR) mRNA and protein, and no significant variation was observed in 1alpha,25(OH)2D3-dependent induction of the endogenous 24-hydroxylase gene, or of a transiently transfected 1alpha,25(OH)2D3-sensitive reporter gene. The antiproliferative effects of 1alpha,25(OH)2D3 and EB1089 in SCC25 cells were analyzed by screening more than 4,500 genes on two cDNA microarrays, yielding 38 up-regulated targets, including adhesion molecules, growth factors, kinases, and transcription factors. Genes encoding factors implicated in cell cycle regulation were induced, including the growth arrest and DNA damage gene, gadd45alpha, and the serum- and glucocorticoid-inducible kinase gene, sgk. Induction of GADD45alpha protein in EB1089-treated cells was confirmed by Western blotting. Moreover, while expression of proliferating cell nuclear antigen (PCNA) was reduced in EB1089-treated cells, coimmunoprecipitation studies revealed increased association between GADD45alpha and PCNA in treated cells, consistent with the capacity of GADD45alpha to stimulate DNA repair. While 1alpha,25(OH)2D3 and EB1089 modestly induced transcripts encoding the cyclin-dependent kinase inhibitor p21(waf1/cip1), no changes in protein levels were observed, indicating that p21(waf1/cip1) induction does not contribute to the antiproliferative effects of 1alpha,25(OH)2D3 and EB1089 in SCC cells. Finally, in partially resistant SCC9 cells, there was extensive loss of target gene regulation (10 of 10 genes tested), indicating that resistance arises from widespread loss of 1alpha,25(OH)2D3-dependent gene regulation in the presence of normal levels of functional VDRs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435613     DOI: 10.1210/mend.15.7.0655

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  30 in total

Review 1.  Vitamin D and cancer: a review of molecular mechanisms.

Authors:  James C Fleet; Marsha DeSmet; Robert Johnson; Yan Li
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

2.  Convergence of vitamin D and retinoic acid signalling at a common hormone response element.

Authors:  Luz Tavera-Mendoza; Tian-Tian Wang; Benjamin Lallemant; Rui Zhang; Yoshihiko Nagai; Véronique Bourdeau; Mario Ramirez-Calderon; Julie Desbarats; Sylvie Mader; John H White
Journal:  EMBO Rep       Date:  2006-02       Impact factor: 8.807

Review 3.  Vitamin D signaling, infectious diseases, and regulation of innate immunity.

Authors:  John H White
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

4.  Serine/threonine protein kinase SGK1 in glucocorticoid-dependent transdifferentiation of pancreatic acinar cells to hepatocytes.

Authors:  Karen Wallace; Quan Long; Emma A Fairhall; Keith A Charlton; Matthew C Wright
Journal:  J Cell Sci       Date:  2011-01-11       Impact factor: 5.285

Review 5.  Vitamin D receptor and RXR in the post-genomic era.

Authors:  Mark D Long; Lara E Sucheston-Campbell; Moray J Campbell
Journal:  J Cell Physiol       Date:  2015-04       Impact factor: 6.384

6.  SGK1-dependent stimulation of intestinal SGLT1 activity by vitamin D.

Authors:  Rexhep Rexhepaj; Ioana Alesutan; Shuchen Gu; Lisann Pelzl; Melanie Eichenmüller; Ganesh Pathare; Michael Föller; Dietmar Kuhl; Florian Lang
Journal:  Pflugers Arch       Date:  2011-07-07       Impact factor: 3.657

7.  Renal Ca2+ handling in sgk1 knockout mice.

Authors:  Diana Sandulache; Florian Grahammer; Ferruh Artunc; Guido Henke; Azeemudeen Hussain; Omaima Nasir; Andreas Mack; Björn Friedrich; Volker Vallon; Peer Wulff; Dietmar Kuhl; Monica Palmada; Florian Lang
Journal:  Pflugers Arch       Date:  2006-05-10       Impact factor: 3.657

Review 8.  Vitamin D and cancer: the promise not yet fulfilled.

Authors:  Daniel D Bikle
Journal:  Endocrine       Date:  2014-01-09       Impact factor: 3.633

9.  Suppression of death receptor-mediated apoptosis by 1,25-dihydroxyvitamin D3 revealed by microarray analysis.

Authors:  Xiaohui Zhang; Pengfei Li; Junying Bao; Santo V Nicosia; Honggang Wang; Steven A Enkemann; Wenlong Bai
Journal:  J Biol Chem       Date:  2005-08-10       Impact factor: 5.157

Review 10.  Potent 19-norvitamin D analogs for prostate and liver cancer therapy.

Authors:  Atsushi Kittaka; Akihiro Yoshida; Kun-Chun Chiang; Masashi Takano; Daisuke Sawada; Toshiyuki Sakaki; Tai C Chen
Journal:  Future Med Chem       Date:  2012-10       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.